Steven Ramael

Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial

Stephan Glund, Joachim Stangier, Michael Schmohl et al. · The Lancet · 2015 · 318 citations

Medicine, Pharmacology, Pharmacotherapy +10

First Human Exposure of Org 25969, a Novel Agent to Reverse the Action of Rocuronium Bromide

Francois Gijsenbergh, Steven Ramael, Natalie Houwing et al. · Anesthesiology · 2005 · 310 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: A double-blind, randomized, placebo-controlled study in healthy male volunteers

Arthur Bergman, Catherine Stevens, Yanyan Zhou et al. · Clinical Therapeutics · 2006 · 266 citations

Pharmacy, Pharmacokinetics, Pharmacology +10

A randomised study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran

Viktoria Moschetti, Stephen H. Norris, Joachim Stangier et al. · Thrombosis and Haemostasis · 2015 · 245 citations

Pharmacy, Pharmacokinetics, Pharmacology +8

Levetiracetam Intravenous Infusion: A Randomized, Placebo‐controlled Safety and Pharmacokinetic Study

Steven Ramael, Agnès Daoust, Christian Otoul et al. · Epilepsia · 2006 · 192 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16